Labshake search

1 - 4 of 4 citations for O'nyong'nyong Virus VLP since 2019

• Human norovirus infection of primary B cells triggers immune activation in vitro

  Carmen Mirabelli, et al., bioRxiv - Microbiology 2021

  Quote: ... HNoV GII.4 virus-like particles (VLPs) were purchased from The Native Antigen Company, Poly (I:C ...
• Fucoidan but not 2’-Fucosyllactose could inhibit human norovirus replication in zebrafish larvae

  Malcolm Turk Hsern Tan, et al., bioRxiv - Microbiology 2020

  Quote: ... NoV GII.4 VLPs (1.1 mg/ml, purity greater than 95%, The Native Antigen Company, UK) were pre-incubated with the fucoidan (from Fucus vesiculosus ...
• eCovSens-Ultrasensitive Novel In-House Built Printed Circuit Board Based Electrochemical Device for Rapid Detection of nCovid-19 antigen, a spike protein domain 1 of SARS-CoV-2

  Subhasis Mahari, et al., bioRxiv - Bioengineering 2020

  Quote: ... Human Immunodeficiency Virus (HIV) and Avian Influenza Virus (AIV) Ag were obtained from The Native Antigen Company (Oxford, UK). Aurdino software has been used in the in-house built device and the hardware include a printed Circuit Board (PCB) ...
• A microfluidic strategy to capture antigen-specific high affinity B cells

  Ahmed M. Alhassan, et al., bioRxiv - Bioengineering 2023

  Quote: ... we prepared 300 nM solutions of influenza A/PR/8/34 virus H1N1 haemagglutinin (HA) recombinant antigen (or Rec-HA; The Native Antigen Company, Kidlington, Oxfordshire, UK) in 1x PBS ...